Answer
The Brancaster Pharma Limited product histamine dihydrochloride 0.5 mg/0.5 mL solution for injection is indicated as maintenance therapy for adults with acute myeloid leukaemia in first remission receiving concomitant interleukin-2, although efficacy has not been fully demonstrated in patients older than 60.
Sources for this answer
- Histamine dihydrochloride 0.5 mg/0.5 ml solution for injectionBrancaster Pharma Limited · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked